Filter results
Type
Audience
Last updated
Topics
-
Life Saving Drugs Program – Pompe disease – Medicines review protocol
Resources › Publications4 July 2019 - This final protocol describes the methodology reviewers will follow to assess use of Life Saving Drugs Program medicines for Pompe disease.
-
Life Saving Drugs Program – Fabry disease – Medicines review protocol
Resources › Publications18 March 2019 - This final protocol describes the methodology reviewers will follow to assess use of Life Saving Drugs Program medicines for Fabry disease.
-
COVID-19 vaccination – Pregnancy, Breastfeeding and the COVID-19 vaccines
Resources › Videos19 July 2022 - Information in Auslan for people with disability about pregnancy, breastfeeding and the COVID-19 vaccines.
-
Life Saving Drugs Program – Asfotase alfa (Strensiq®) outcome statement – 13 May 2022
Resources › Publications13 May 2022 - This document states the outcome of Alexion Pharmaceuticals Australasia's application to include asfotase alfa on the Life Saving Drugs Program.
-
Life Saving Drugs Program – Asfotase alfa (Strensiq®) outcome statement
Resources › Publications2 February 2021 - This document states the outcome of Alexion Pharmaceuticals Australasia's application to include asfotase alfa on the Life Saving Drugs Program.
-
Privacy notice for vaccination providers using the COVID-19 Vaccine Administrative System (CVAS)
Using our websites › Website privacy policy5 May 2025 - Find out how we manage any personal information we collect in relation to the COVID-19 Vaccine Administrative System (CVAS).
-
Budget 2019–20: Prioritising Mental Health – Perinatal Mental Health and Wellbeing Program
Resources › Publications31 March 2019 - This Budget fact sheet outlines how the Government will support the mental health of expectant and new parents through an innovative Perinatal Mental Health and Wellbeing Program.
-
Top 3 questions – What is long COVID, is it becoming more common, do vaccines reduce your chance of getting it
News and media20 May 2022 - Deputy Chief Medical Officer, Professor Michael Kidd, answers the Top Three questions across our channels.
-
Budget 2019–20: Investing in Health and Medical Research – fighting diabetes
Resources › Publications31 March 2019 - This Budget fact sheet outlines how the Government will provide $56 million for research that will give new hope and support to the more than 120,000 Australian children and adults living with type 1 diabetes.
-
ATAGI statement on revised recommendations on the use of COVID-19 Vaccine AstraZeneca, 17 June 2021
News and media17 June 2021 - A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on the AstraZeneca COVID-19 vaccine in response to new vaccine safety concerns.